SYSTOLIC HYPERTENSION IN THE ELDERLY

老年人的收缩性高血压

• 批准号: 3646917
• 负责人: W MCFATE SMITH
• 金额: $ 37.18万
• 依托单位: MEDICAL RESEARCH INSTITUTE OF SAN FRAN
• 依托单位国家: 美国
• 财政年份: 1984
• 资助国家: 美国
• 起止时间: 1984-06-30 至 1991-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/3646917
• 关键词: aging; antihypertensive agents; cardiovascular disorder chemotherapy; cooperative study; drug adverse effect; human mortality; human subject; human therapy evaluation; hypertension; longitudinal human study; stroke

This Contractor serves as a clinical center in the Systolic Hypertension in the Elderly Program (SHEP). SHEP is designed to determine if isolated systolic hypertension should be treated in an elderly population. The general research design is to be implemented in three phases. Phase I will consist of refining the preliminary draft protocol and the development of an operations manual. Phase I is anticipated to last eight months. During Phase II, participants will be recruited, treated, and followed; Phase II will last approximately six years. Phase III is for analysis and dissemination of results. This will require six months.

该承包商是收缩期高血压的临床中心 老年人计划（SHEP）。 SHEP旨在确定是否孤立 收缩压应在老年人群中治疗。 这 一般研究设计将分为三个阶段。 第一阶段会 包括完善初步草案协议和开发 操作手册。 一阶段预计将持续八个月。 期间 第二阶段，将招募，治疗和遵循参与者；第二阶段 将持续大约六年。 第三阶段用于分析和 结果传播。 这将需要六个月。